Abstract

Advanced glycation end products (AGEs) can act as neoantigens to trigger immune responses. Natural IgM antibodies against AGEs recognize multiple molecules, including DNA and chemically modified proteins. There is a close relationship between the formation of AGEs and innate immune responses. Our findings highlight AGEs and related modified proteins as a source of multispecific natural antibodies Advanced glycation end products (AGEs) are a heterogeneous and complex group of compounds that are formed when reducing sugars, such as dehydroascorbic acid, react in a nonenzymatic way with amino acids in proteins and other macromolecules. AGEs are prevalent in the diabetic vasculature and contribute to the development of atherosclerosis. The presence and accumulation of AGEs in many different cell types affect the extracellular and intracellular structure and function. In the present study, we studied the immune response to the dehydroascorbic acid-derived AGEs and provide multiple lines of evidence suggesting that the AGEs could be an endogenous source of innate epitopes recognized by natural IgM antibodies. Prominent IgM titers to the AGEs were detected in the sera of normal mice and were significantly accelerated by the immunization with the AGEs. Patients with systemic lupus erythematosus (SLE), a potentially fatal systemic autoimmune disease characterized by the increased production of autoantibodies, showed significantly higher serum levels of the IgM titer against the AGEs than healthy individuals. A progressive increase in the IgM response against the AGEs was also observed in the SLE-prone mice. Strikingly, a subset of monoclonal antibodies, showing a specificity toward the AGEs, prepared from normal mice immunized with the AGEs and from the SLE mice cross-reacted with the double-stranded DNA. Moreover, they also cross-reacted with several other modified proteins, including the acetylated proteins, suggesting that the multiple specificity of the antibodies might be ascribed, at least in part, to the increased electronegative potential of the proteins. These findings suggest that the protein modification by the endogenous carbonyl compounds, generating electronegative proteins, could be a source of multispecific natural antibodies.

Highlights

  • Advanced glycation end products (AGEs) can act as neoantigens to trigger immune responses

  • We studied the immune response to the dehydroascorbic acid-derived AGEs and provide multiple lines of evidence suggesting that the AGEs could be an endogenous source of innate epitopes recognized by natural IgM antibodies

  • We studied the innate immune response to the Dehydroascorbic acid (DHA)-derived AGEs and provided multiple lines of evidence suggesting that the AGEs could be an endogenous source of innate epitopes recognized by natural antibodies

Read more

Summary

Background

Advanced glycation end products (AGEs) can act as neoantigens to trigger immune responses. We studied the immune response to the dehydroascorbic acid-derived AGEs and provide multiple lines of evidence suggesting that the AGEs could be an endogenous source of innate epitopes recognized by natural IgM antibodies. It has been suggested that, because the vitamin C levels are high in a variety of tissues, DHA and its degradation products could be causally involved in the formation of AGEs in vivo Modified forms, such as AGEs, generated on self-antigens could be an important target of the immune response. We studied the innate immune response to the DHA-derived AGEs and provided multiple lines of evidence suggesting that the AGEs could be an endogenous source of innate epitopes recognized by natural antibodies. Based on the findings that the natural Abs cross-reacted with dsDNA and several other modified proteins, including the acetylated proteins, we suggest a mechanism, in which the electronegative potential of antigens might be involved, at least in part, in the recognition by the natural Abs

EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call